BioSpace News Archive

Business

NeuroRx on the Move: An Interview with Founder and CEO Jonathan Javitt

Like many biopharma companies, the global COVID-19 pandemic has caused delays while also offering opportunities for NeuroRx.

January 14, 2021
·
5 min read
·
Mark Terry
Drug Development

J&J’s One-Shot COVID-19 Vaccine Appears Safe and Effective in Interim Data

Johnson & Johnson published interim Phase I/IIa data in the New England Journal of Medicine showing its single-dose COVID-19 vaccine candidate created an immune response that lasted at least 71 days.

January 14, 2021
·
4 min read
·
Mark Terry
Business

FDA Vet Bumped Up to Top Spot by Biden Admin on Interim Basis

Janet Woodcock, the longtime director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration is set to take over the top spot of the regulatory agency on an interim basis following the presidential inauguration of Joe Biden.

January 14, 2021
·
2 min read
·
Alex Keown
Business

Shark Tank’s Mark Cuban Dives into Generic Drug Market

Billionaire entrepreneur Mark Cuban, best known as the owner of the Dallas Mavericks and an investor on the ABC business reality series “Shark Tank,” is diving into generic drugs with a new startup, dubbed Mark Cuban Cost Plus Drug Company.

January 14, 2021
·
2 min read
·
Alex Keown
Drug Development

Will Murky Trial Data Undercut Landos’ $100 Million IPO Launch?

On January 4, the company announced slightly murky data from its first-in-patients 12-week Phase II proof-of-concept trial of BT-11 for mild to moderate ulcerative colitis.

January 14, 2021
·
3 min read
·
Mark Terry
BioForest

Research Roundup: COVID-19 Severity and Later Respiratory Problems and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

January 14, 2021
·
5 min read
·
Mark Terry
Drug Development

Mapping the Future of the COVID-19 Pandemic

A drop-off in virulence is possible for the SARS-CoV-2 virus -- once enough of the global population has been vaccinated or exposed to it, according to a new study from scientists at Emory University and The Pennsylvania State University.

January 14, 2021
·
2 min read
·
Mark Zipkin
Existing Drug Combo Shows Potential for First Meth Addiction Treatment

With meth related deaths on the rise and no FDA-approved treatments, researchers are finding repurposed drugs that may help addicts stay clean.

January 14, 2021
·
3 min read
·
Kate Goodwin
JPM2021, Day 3: Sanofi, Jazz Pharma, Replimune and More

Here’s a look at some of the stories that emerged from the conference on Wednesday.

January 14, 2021
·
4 min read
·
Alex Keown
Policy

Drug Prices Top of Mind as Pharma Leaders Consider Policies Under Biden

In many regards, the incoming Biden Administration is expected to be a redux of the Obama Administration, likely with strong support for scientific research and a reinvigoration of the Affordable Care Act. Yet concerns of pricing controls still loom.

January 14, 2021
·
5 min read
·
Gail Dutton